What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.04%Below 5Y avg (2.05%)
Annual Rate
MYR 0.01Paid semi-annual
Payout Ratio
12.5%Sustainable
Payback Period
12.6 yr
Next Ex-Dividend
Nov 23, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.77BMYR
1.17B · vs all stocks (USD)
Updated Oct 24, 2026
Trailing P/E
23.00x
vs Medical Instruments & Supplies peers
Updated Oct 24, 2026
Revenue (TTM)
4.23BMYR
1.03B · vs all stocks (USD)
Updated Oct 24, 2026
Profit Margin
7.28%
vs Medical Instruments & Supplies peers
Updated Oct 24, 2026
Beta
0.3730x
vs all stocks
Updated Oct 24, 2026
52-Week Change
34.31%
vs all stocks
Updated Oct 24, 2026
Forward Annual Dividend Yield
1.04%
vs all stocks
Updated Oct 24, 2026
Market Capitalization
4.77BMYR
1.17B · vs all stocks (USD)
Updated Oct 24, 2026
Enterprise Value
6.95BMYR
1.70B · vs all stocks (USD)
Updated Oct 24, 2026
Trailing P/E
23.00x
vs Medical Instruments & Supplies peers
Updated Oct 24, 2026
Forward P/E
22.30x
vs Medical Instruments & Supplies peers
Updated Oct 24, 2026
PEG Ratio
0.1705x
vs Medical Instruments & Supplies peers
Updated Oct 24, 2026
Price to Sales (TTM)
1.74x
vs Medical Instruments & Supplies peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 1.13×.Updated Oct 24, 2026
Price to Book (MRQ)
1.48x
vs Medical Instruments & Supplies peers
Updated Oct 24, 2026
Enterprise to Revenue
1.64x
vs Medical Instruments & Supplies peers
Updated Oct 24, 2026
Enterprise to EBITDA
9.27x
vs Medical Instruments & Supplies peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 11.17×.Updated Oct 24, 2026
Profit Margin
7.28%
vs Medical Instruments & Supplies peers
Updated Oct 24, 2026
Operating Margin
17.32%
vs Medical Instruments & Supplies peers
Updated Oct 24, 2026
Return on Assets (TTM)
4.26%
vs Medical Instruments & Supplies peers
Updated Oct 24, 2026
Return on Equity (TTM)
6.34%
vs Medical Instruments & Supplies peers
Updated Oct 24, 2026
Revenue (TTM)
4.23BMYR
1.03B · vs all stocks (USD)
Updated Oct 24, 2026
Revenue per Share (TTM)
0.5280MYRUpdated Oct 24, 2026
Quarterly Revenue Growth
39.70%
vs Medical Instruments & Supplies peers
Updated Oct 24, 2026
Gross Profit (TTM)
406.29MMYR
99.24M · vs all stocks (USD)
Updated Oct 24, 2026
EBITDA (TTM)
622.60MMYR
152.07M · vs all stocks (USD)
Updated Oct 24, 2026
Net Income (TTM)
307.96MMYR
75.22M · vs all stocks (USD)
Updated Oct 24, 2026
Quarterly Earnings Growth (YoY)
352.60%
vs Medical Instruments & Supplies peers
Updated Oct 24, 2026
Operating Cash Flow (TTM)
527.75MMYR
128.90M · vs all stocks (USD)
Updated Oct 24, 2026
Levered Free Cash Flow (TTM)
327.99MMYR
80.11M · vs all stocks (USD)
Updated Oct 24, 2026
Forward Annual Dividend Rate
0.0096MYRUpdated Oct 24, 2026
Forward Annual Dividend Yield
1.04%
vs all stocks
Updated Oct 24, 2026
Trailing Annual Dividend Rate
0.0168MYRUpdated Oct 24, 2026
Trailing Annual Dividend Yield
1.83%
vs all stocks
Updated Oct 24, 2026
5-Year Average Dividend Yield
2.05%
vs all stocks
Updated Oct 24, 2026
Payout Ratio
12.50%
vs Medical Instruments & Supplies peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 42%.Updated Oct 24, 2026
Minority Interest (Equity)
25.55MMYRFY2025 · Aug 31, 2025
Revenue
3.49BMYRFY2025 · Aug 31, 2025
Cost of Goods Sold
3.00BMYRFY2025 · Aug 31, 2025
Gross Profit
496.88MMYRFY2025 · Aug 31, 2025
Operating Income
22.07MMYR
5.39M · vs all stocks (USD)
FY2025 · Aug 31, 2025
Pre-tax Income
148.20MMYRFY2025 · Aug 31, 2025
Income Tax Expense
25.35MMYRFY2025 · Aug 31, 2025
Net Income
122.85MMYRFY2025 · Aug 31, 2025
EBIT
170.41MMYRFY2025 · Aug 31, 2025
EBITDA (Income Statement)
411.34MMYRFY2025 · Aug 31, 2025
Selling, General & Administrative
481.02MMYRFY2025 · Aug 31, 2025
Other Operating Expenses
-57.00KMYRFY2025 · Aug 31, 2025
Non-operating Interest Income
28.52MMYRFY2025 · Aug 31, 2025
Non-operating Interest Expense
22.21MMYRFY2025 · Aug 31, 2025
EPS (Basic)
0.0131MYRFY2025 · Aug 31, 2025
EPS (Diluted)
0.0131MYRFY2025 · Aug 31, 2025
Minority Interests (P&L)
5.60MMYRFY2025 · Aug 31, 2025
Operating Cash Flow
106.32MMYRFY2025 · Aug 31, 2025
Free Cash Flow
91.58MMYRFY2025 · Aug 31, 2025
Cash & Cash Equivalents (End of Period)
296.95MMYRFY2025 · Aug 31, 2025
Starting Profit (CF Statement)
148.20MMYRFY2025 · Aug 31, 2025
Stock-based Compensation
257.00KMYRFY2025 · Aug 31, 2025
Other Non-cash Items
-6.33MMYRFY2025 · Aug 31, 2025
Change in Accounts Receivable (CF)
-80.78MMYRFY2025 · Aug 31, 2025
Change in Other Assets/Liabilities
44.98MMYRFY2025 · Aug 31, 2025
Capital Expenditures
14.74MMYRFY2025 · Aug 31, 2025
Net Intangibles (CF)
-399.00KMYRFY2025 · Aug 31, 2025
Net Acquisitions
0.00MYRFY2025 · Aug 31, 2025
Purchase of Investments
-178.19MMYRFY2025 · Aug 31, 2025
Sale of Investments
576.66MMYRFY2025 · Aug 31, 2025
Other Investing Activity
15.43MMYRFY2025 · Aug 31, 2025
Net Investing Cash Flow
428.63MMYRFY2025 · Aug 31, 2025
Long-term Debt Issuance
1.19BMYRFY2025 · Aug 31, 2025
Long-term Debt Payments
-796.86MMYRFY2025 · Aug 31, 2025
Other Financing Charges
-1.20BMYRFY2025 · Aug 31, 2025
Net Financing Cash Flow
-799.43MMYRFY2025 · Aug 31, 2025
Shares Outstanding
8.02BSharesUpdated Oct 24, 2026
Float Shares
4.94BSharesUpdated Oct 24, 2026
% Held by Insiders
38.27%
vs all stocks
Updated Oct 24, 2026
% Held by Institutions
20.50%
vs all stocks
Updated Oct 24, 2026
Total Cash (MRQ)
978.25MMYR
238.94M · vs all stocks (USD)
Updated Oct 24, 2026
Total Cash per Share (MRQ)
0.1220MYRUpdated Oct 24, 2026
Total Debt (MRQ)
852.99MMYR
208.34M · vs all stocks (USD)
Updated Oct 24, 2026
Total Debt to Equity (MRQ)
0.1706x
vs Medical Instruments & Supplies peers
Updated Oct 24, 2026
Current Ratio (MRQ)
2.96x
vs Medical Instruments & Supplies peers
Updated Oct 24, 2026
Book Value per Share (MRQ)
0.6200MYRUpdated Oct 24, 2026
Total Assets
6.28BMYR
1.53B · vs all stocks (USD)
FY2025 · Aug 31, 2025
Total Current Assets
1.45BMYRFY2025 · Aug 31, 2025
Total Liabilities
1.50BMYRFY2025 · Aug 31, 2025
Total Non-current Assets
4.82BMYRFY2025 · Aug 31, 2025
Total Non-current Liabilities
961.50MMYRFY2025 · Aug 31, 2025
Total Current Liabilities
538.30MMYRFY2025 · Aug 31, 2025
Cash
295.97MMYRFY2025 · Aug 31, 2025
Cash & Cash Equivalents
295.97MMYRFY2025 · Aug 31, 2025
Other Short-term Investments
262.51MMYRFY2025 · Aug 31, 2025
Accounts Receivable
423.39MMYRFY2025 · Aug 31, 2025
Inventory
344.92MMYRFY2025 · Aug 31, 2025
Accounts Payable
196.08MMYRFY2025 · Aug 31, 2025
Retained Earnings
4.21BMYRFY2025 · Aug 31, 2025
Total Shareholders' Equity
4.78BMYR
1.17B · vs all stocks (USD)
FY2025 · Aug 31, 2025
52-Week Low
0.5300MYRUpdated Oct 24, 2026
52-Week High
0.9500MYRUpdated Oct 24, 2026
52-Week Change
34.31%
vs all stocks
Updated Oct 24, 2026
Beta
0.3730x
vs all stocks
Updated Oct 24, 2026
50-Day MA
0.7525MYRUpdated Oct 24, 2026
200-Day MA
0.6952MYRUpdated Oct 24, 2026
Avg 10-Day Volume
63.99MSharesUpdated Oct 24, 2026
Avg 30-Day Volume
69.98MSharesUpdated Oct 24, 2026
Diluted EPS (TTM)
0.0400MYRUpdated Oct 24, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
What customers owe has grown three years running, while it clears stock quickly and pays suppliers quickly.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.67: safe zoneNotable
Altman Z-Score: 3.67
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $1.17B, above the global median of $1.14BNotable
Market cap (USD): 1,165,240,828.307Global Median: 1,137,180,293.291
Revenue is $1.03B, above the global median of $566.17MNotable